{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:44:22Z","timestamp":1774615462417,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T00:00:00Z","timestamp":1287446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00535-010-0334-1","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T07:47:45Z","timestamp":1287388065000},"page":"183-190","source":"Crossref","is-referenced-by-count":34,"title":["Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?"],"prefix":"10.1007","volume":"46","author":[{"given":"Yao-Chun","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyh-Ming","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeng-Huey","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Lun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwai-Jeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei-Tang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,19]]},"reference":[{"issue":"5","key":"334_CR1","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466\u201379.","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"334_CR2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","volume":"102","author":"NJ Talley","year":"1992","unstructured":"Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102(4 Pt 1):1259\u201368.","journal-title":"Gastroenterology"},{"issue":"6","key":"334_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","volume":"19","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19(6):643\u201354.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"334_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2036.2003.01706.x","volume":"18","author":"HB El-Serag","year":"2003","unstructured":"El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003;18(4):387\u201393.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 4","key":"334_CR5","first-page":"iv10-2","volume":"50","author":"P Moayyedi","year":"2002","unstructured":"Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut. 2002;50(Suppl 4):iv10-2.","journal-title":"Gut"},{"issue":"5","key":"334_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00019053-200220050-00006","volume":"20","author":"L Agreus","year":"2002","unstructured":"Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 2002;20(5):347\u201355.","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"334_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","volume":"3","author":"M Camilleri","year":"2005","unstructured":"Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3(6):543\u201352.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"334_CR8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"98","author":"G Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98(4):783\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"334_CR9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127(4):1239\u201355.","journal-title":"Gastroenterology"},{"issue":"6","key":"334_CR10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115(6):1346\u201352.","journal-title":"Gastroenterology"},{"issue":"3","key":"334_CR11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","volume":"121","author":"J Tack","year":"2001","unstructured":"Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001;121(3):526\u201335.","journal-title":"Gastroenterology"},{"issue":"5","key":"334_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2982.2006.00896.x","volume":"19","author":"JA Lunding","year":"2007","unstructured":"Lunding JA, Gilja OH, Hausken T, Bayati A, Mattsson H, Berstad A. Distension-induced gastric accommodation in functional dyspepsia: effect of autonomic manipulation. Neurogastroenterol Motil. 2007;19(5):365\u201375.","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"334_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004836-199706000-00006","volume":"24","author":"HP Parkman","year":"1997","unstructured":"Parkman HP, Miller MA, Trate D, Knight LC, Urbain JL, Maurer AH, et al. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol. 1997;24(4):214\u20139.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"334_CR14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2009.12.057","volume":"138","author":"RM Zagari","year":"2010","unstructured":"Zagari RM, Law GR, Fuccio L, Cennamo V, Gilthorpe MS, Forman D, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010;138(4):1302\u201311.","journal-title":"Gastroenterology"},{"issue":"10","key":"334_CR15","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1038\/ajg.2009.328","volume":"104","author":"YC Hsu","year":"2009","unstructured":"Hsu YC, Liou JM, Liao SC, Yang TH, Wu HT, Hsu WL, et al. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria. Am J Gastroenterol. 2009;104(10):2534\u201342.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"334_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.gastro.2009.03.039","volume":"137","author":"P Aro","year":"2009","unstructured":"Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137(1):94\u2013100.","journal-title":"Gastroenterology"},{"issue":"3","key":"334_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","volume":"96","author":"SJ Veldhuyzen van Zanten","year":"2001","unstructured":"Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001;96(3):689\u201396.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"334_CR18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127(5):1329\u201337.","journal-title":"Gastroenterology"},{"key":"334_CR19","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006(4);CD001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"issue":"2","key":"334_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","volume":"5","author":"WH Wang","year":"2007","unstructured":"Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5(2):178\u201385. (quiz 40).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"334_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00535-008-2167-8","volume":"43","author":"B Geeraerts","year":"2008","unstructured":"Geeraerts B, Tack J. Functional dyspepsia: past, present, and future. J Gastroenterol. 2008;43(4):251\u20135.","journal-title":"J Gastroenterol"},{"issue":"5","key":"334_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1440-1746.2002.02713.x","volume":"17","author":"WH Hu","year":"2002","unstructured":"Hu WH, Lam KF, Wong YH, Lam CL, Hui WM, Lai KC, et al. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol. 2002;17(5):545\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"334_CR23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.51.4.502","volume":"51","author":"WM Wong","year":"2002","unstructured":"Wong WM, Wong BC, Hung WK, Yee YK, Yip AW, Szeto ML, et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut. 2002;51(4):502\u20136.","journal-title":"Gut"},{"issue":"12","key":"334_CR24","first-page":"1081","volume":"89","author":"MB Lee","year":"1990","unstructured":"Lee MB, Lee YJ, Yen LL, Lin MH, Lue BH. Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice. J Formos Med Assoc. 1990;89(12):1081\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"334_CR25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1440-1746.2005.04034.x","volume":"21","author":"YC Lee","year":"2006","unstructured":"Lee YC, Wang HP, Chiu HM, Liao SC, Huang SP, Lai YP, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006;21(5):798\u2013804.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"334_CR26","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2165\/00003495-200161120-00011","volume":"61","author":"AJ Matheson","year":"2001","unstructured":"Matheson AJ, Jarvis B. Lansoprazole: an update of its place in the management of acid-related disorders. Drugs. 2001;61(12):1801\u201333.","journal-title":"Drugs"},{"issue":"3","key":"334_CR27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(24)37150-2","volume":"283","author":"Y Mine","year":"1997","unstructured":"Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther. 1997;283(3):1000\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"334_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2005.02472.x","volume":"21","author":"Y Kinoshita","year":"2005","unstructured":"Kinoshita Y, Hashimoto T, Kawamura A, Yuki M, Amano K, Sato H, et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharmacol Ther. 2005;21(Suppl 2):37\u201341.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"334_CR29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2036.2005.02473.x","volume":"21","author":"M Otaka","year":"2005","unstructured":"Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y, et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther. 2005;21(Suppl 2):42\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"334_CR30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","volume":"16","author":"BI Hallerback","year":"2002","unstructured":"Hallerback BI, Bommelaer G, Bredberg E, Campbell M, Hellblom M, Lauritsen K, et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther. 2002;16(5):959\u201367.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"334_CR31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1746.2006.04493.x","volume":"22","author":"T Hiyama","year":"2007","unstructured":"Hiyama T, Yoshihara M, Matsuo K, Kusunoki H, Kamada T, Ito M, et al. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol. 2007;22(3):304\u201310.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"334_CR32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.mcg.0000123164.86324.24","volume":"38","author":"RJ Laheij","year":"2004","unstructured":"Laheij RJ, De Koning RW, Horrevorts AM, Rongen RJ, Rossum LG, Witteman EM, et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol. 2004;38(6):490\u20135.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"334_CR33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.mcg.0000225620.02094.c3","volume":"42","author":"KA Gwee","year":"2008","unstructured":"Gwee KA, Hwang JE, Ho KY, Yeoh KG, Lum CF, Ang PK. In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population. J Clin Gastroenterol. 2008;42(2):134\u20138.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"334_CR34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006;354(8):832\u201340.","journal-title":"N Engl J Med"},{"issue":"11","key":"334_CR35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12(11):1055\u201365.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"334_CR36","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1572-0241.2006.00751.x","volume":"101","author":"SV Zanten van","year":"2006","unstructured":"van Zanten SV, Armstrong D, Chiba N, Flook N, White RJ, Chakraborty B, et al. Esomeprazole 40\u00a0mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled \u201cENTER\u201d trial. Am J Gastroenterol. 2006;101(9):2096\u2013106.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"334_CR37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1365-2036.2006.02845.x","volume":"23","author":"NJ Talley","year":"2006","unstructured":"Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D\u2019Elia TV, et al. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006;23(7):923\u201336.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"334_CR38","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2005.11.058","volume":"130","author":"EJ Irvine","year":"2006","unstructured":"Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1538\u201351.","journal-title":"Gastroenterology"},{"issue":"8","key":"334_CR39","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/archinte.160.8.1192","volume":"160","author":"J Danesh","year":"2000","unstructured":"Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med. 2000;160(8):1192\u20138.","journal-title":"Arch Intern Med"},{"issue":"10","key":"334_CR40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1046\/j.1365-2036.2000.00840.x","volume":"14","author":"K Adachi","year":"2000","unstructured":"Adachi K, Katsube T, Kawamura A, Takashima T, Yuki M, Amano K, et al. CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole. Aliment Pharmacol Ther. 2000;14(10):1259\u201366.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-010-0334-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0334-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:32:12Z","timestamp":1740605532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-010-0334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,19]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s00535-010-0334-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,19]]}}}